{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05852015",
            "orgStudyIdInfo": {
                "id": "2000028537"
            },
            "secondaryIdInfos": [
                {
                    "id": "1K23AT011342-01",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1K23AT011342-01"
                }
            ],
            "organization": {
                "fullName": "Yale University",
                "class": "OTHER"
            },
            "briefTitle": "Digital Mindfulness-Based Treatment for Substance Use Disorder Recovery",
            "officialTitle": "Digital Mindfulness-Based Treatment for Individuals in Early Recovery From Substance Use Disorders",
            "therapeuticArea": [
                "Other"
            ],
            "study": "digital-mindfulness-based-treatment-for-substance-use-disorder-recovery"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-05-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-04-17",
            "studyFirstSubmitQcDate": "2023-04-30",
            "studyFirstPostDateStruct": {
                "date": "2023-05-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-11",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Corey Roos",
                "investigatorTitle": "Assistant Professor of Psychiatry",
                "investigatorAffiliation": "Yale University"
            },
            "leadSponsor": {
                "name": "Yale University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Center for Complementary and Integrative Health (NCCIH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to evaluate the feasibility and acceptability of a digital mindfulness-based treatment for individuals in early recovery from substance use disorders. Participants are randomized to treatment-as-usual (TAU) or TAU plus the digital mindfulness-based treatment. The digital treatment will be completed over an 8-week period."
        },
        "conditionsModule": {
            "conditions": [
                "Substance Use Disorders"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 34,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment-as-Usual (TAU)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "TAU consists of weekly outpatient-based group therapy",
                    "interventionNames": [
                        "Behavioral: Treatment-as-Usual (TAU)"
                    ]
                },
                {
                    "label": "TAU Plus Digital Mindfulness-Based Treatment",
                    "type": "EXPERIMENTAL",
                    "description": "TAU consists of weekly outpatient-based group therapy. The digital mindfulness-based treatment is multimedia app-based program teaching mindfulness skills.",
                    "interventionNames": [
                        "Behavioral: Treatment-as-Usual (TAU)",
                        "Behavioral: Digital Mindfulness Treatment"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Treatment-as-Usual (TAU)",
                    "description": "TAU consists of weekly outpatient-based group therapy for substance use disorder",
                    "armGroupLabels": [
                        "TAU Plus Digital Mindfulness-Based Treatment",
                        "Treatment-as-Usual (TAU)"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Digital Mindfulness Treatment",
                    "description": "The digital mindfulness-based treatment is a multimedia app-based program teaching mindfulness skills to facilitate recovery from substance use disorder",
                    "armGroupLabels": [
                        "TAU Plus Digital Mindfulness-Based Treatment"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Adherence to the digital treatment",
                    "description": "Percent of randomized participants completing 50% or more of the digital treatment modules",
                    "timeFrame": "8-week treatment period that begins on the day participants are randomized"
                },
                {
                    "measure": "Completion rates for the post-treatment assessment visit",
                    "description": "Percent of randomized participants completing post-treatment assessment visit",
                    "timeFrame": "Approximately 9 weeks after randomization"
                },
                {
                    "measure": "Completion rates for the follow-up assessment visit",
                    "description": "Percent of randomized participants completing follow-up assessment visit",
                    "timeFrame": "2-month post-treatment follow-up (approximately 16 weeks post-randomization)"
                },
                {
                    "measure": "Completion rates for ecological momentary assessment at baseline",
                    "description": "Percent of randomized participants completing 50% or more of EMA surveys at baseline",
                    "timeFrame": "2-week period at baseline prior to randomization"
                },
                {
                    "measure": "Completion rates for ecological momentary assessment at post-treatment",
                    "description": "Percent of randomized participants completing 50% or more of EMA surveys post-treatment",
                    "timeFrame": "2-week period occurring approximately during weeks 10 and 11 post-randomization"
                },
                {
                    "measure": "Dimensions of treatment acceptability",
                    "description": "Single-items measuring ratings of acceptability dimensions for the digital treatment, including willingness to engage, usability, understandability, engage-ability, visual appeal, helpfulness, skill acquisition, and confidence implementing skills. Scores for each item range from 1 to 5, with higher scores indicating better acceptability.",
                    "timeFrame": "Ratings made at the post-treatment assessment, which is approximately 9 weeks after randomization"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Change in frequency of primary substance use",
                    "description": "The Timeline Follow Back, a calendar-based interview, will be used to assess substance use",
                    "timeFrame": "Baseline through end-of-treatment (end of week 8 post-randomization) and through the 2-month follow-up period (weeks 9 to 16 weeks post-randomization)"
                },
                {
                    "measure": "Change in frequency of any substance use",
                    "description": "The Timeline Follow Back, a calendar-based interview, will be used to assess substance use",
                    "timeFrame": "Baseline through end-of-treatment (end of week 8 post-randomization) and through the 2-month follow-up period (weeks 9 to 16 weeks post-randomization)"
                },
                {
                    "measure": "Change in substance-related problems",
                    "description": "Short-inventory of problems Revised (SIP-R), a self-report questionnaire of substance-related problems. Total score range from 0 to 51, with higher scores indicating greater substance related problems.",
                    "timeFrame": "Baseline through end-of-treatment (end of week 8 post-randomization) and through the 2-month follow-up period (weeks 9 to 16 weeks post-randomization)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* 18 years of age or older\n* Fluent in English and have a 6th grade or higher reading level\n* Have completed 1 month or more of SUD treatment\n* Report use of their primary substance of choice in past 6 months\n* Are not currently enrolled in residential/inpatient treatment\n* Are willing to be randomized\n* Are willing and able to participate for the entire study period\n* Are willing to provide locator information for follow-up\n* Own a working, WIFI-enabled smartphone\n\nExclusion Criteria:\n\n* Current psychotic disorder\n* High suicide risk characterized by suicidal ideation with intent\n* Homicidal ideation posing imminent danger to others\n* Pending legal case, imminent incarceration, or a planned move that results in inability to commit to procedures during the entire study period\n* Participation in the Phase 1 User Testing study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Corey Roos",
                    "role": "CONTACT",
                    "phone": "2036235882",
                    "email": "corey.roos@yale.edu"
                },
                {
                    "name": "Hedy Kober",
                    "role": "CONTACT",
                    "phone": "917-470-8331",
                    "email": "hedy.kober@yale.edu"
                }
            ],
            "locations": [
                {
                    "facility": "1 Church street",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06511",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Corey Roos, PhD",
                            "role": "CONTACT",
                            "phone": "203-623-5882",
                            "email": "corey.roos@yale.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Requests for data sharing will be considered within the context of ongoing and planned research being performed within the research group at Yale in order to avoid duplication of effort and overlap in data analysis that might compromise communication of findings. Data to be shared will be de-identified and transmission electronically and securely, as we have done previously with investigators at other institutions."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "asFound": "Substance Use Disorders",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}